Heather Schneider, Michael Johnson and Tara Thieme spoke on the second webinar in a four-part series co-hosted by Willkie and Taylor Wessing covering various aspects of biosimilars litigation, market access and regulation.
Session 2 of this series focused on key factors decision makers need to be aware of when considering currently pending legislation, including:
- Key provisions of proposed legislation
- European perspectives and approaches to similar issues
To listen to a recording of the event, please click here.